查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
植入式醫療器械市場規模，按產品類型，按設備性質，按最終用途，行業分析報告，區域展望，增長潛力，競爭市場份額和預測，2023-2032
市場調查報告書
商品編碼
1237820

植入式醫療器械市場規模，按產品類型，按設備性質，按最終用途，行業分析報告，區域展望，增長潛力，競爭市場份額和預測，2023-2032

Implantable Medical Devices Market Size, By Product, By Type, By Nature of Device, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 492 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球植入式醫療設備市場將在 2032 年之前實現積極增長，這是由於人們越來越傾向於使用生物材料以獲得更好的生物相容性和治療效果。預計。

此外，植入式醫療器械的一系列技術創新有望提升產品性能和臨床療效。

例如，相干公司將在 2023 年初推出全自動激光系統 AP 530 S，用於植入式醫療設備的標記和紋理□□化。 由於該過程是非接觸式的，因此不存在污染風險，並且可以提高醫療器械的均勻性和質量水平。

知名公司正在開發高端植入技術和數據監控應用程序，以提供有關患者健康和設備性能的臨床數據。 例如，強生公司在 2022 年 3 月透露，該公司的 DePuy Synthes 部門推出了兩種最先進的膝關節植入物，即 ATTUNE 無水泥固定軸承膝關節和 ATTUNE 內側穩定膝關節系統。 通過推出這一新產品，該公司擴大了產品組合併增加了收入份額。

植入式醫療器械市場根據產品、類型、器械性質、最終用途和地區進行細分。

從產品來看，從 2023 年到 2032 年，骨科領域預計將以超過 10.5% 的複合年增長率增長。 對身體屬性的認識不斷提高以及對某些美容標準的偏好不斷增加，預計將推動市場擴張。

在最終用途方面，隨著醫院引入可提高治療效果的尖端植入式設備，預計未來幾年市場將顯著增長。 此外，疾病篩查計劃的增加、治療心髒病和骨科疾病等慢性病的住院人數增加以及心髒病和骨科疾病住院人數的增加預計將對擴大醫院部門。它是

按地區劃分，從 2023 年到 2032 年，拉丁美洲的植入式醫療器械市場預計將以超過 10% 的複合年增長率增長。 該地區的擴張預計將受到該地區不斷擴大的人口基數和醫療旅遊增長的推動。 預計對用於治療各種疾病的技術改進設備的需求也將推動拉丁美洲地區的市場擴張。

報告稱，墨西哥是世界上第二大最受歡迎的醫療旅遊目的地，有 140 至 300 萬人湧入墨西哥尋求負擔得起的治療。

內容

第 1 章研究方法和範圍

第 2 章執行摘要

第 3 章：植入式醫療器械行業洞察

  • 行業格局，2018-2032 年版
  • 影響行業的因素
    • 司機
      • 全球慢性病發病率增加
      • 缺乏器官捐獻者
      • 發達國家的技術進步
      • 發達國家政府對植入式醫療設備的資助增加
      • 更加註重微電子和嵌入式傳感器的開發
      • 採用生物材料來改善生物相容性和治療效果
    • 行業潛在的風險和挑戰
      • 設備成本高
      • 對有源植入式醫療器械的嚴格監管
      • 術後並發症的發生率顯著提高
      • 大量植入式醫療器械召回
  • 增長分析
    • 按產品分類
    • 按類型
    • 由於設備的性質
    • 按最終用途
  • COVID-19 影響分析
  • 監管狀況
    • 美國
    • 歐洲
    • 亞太地區
  • 退款場景
  • 技術概況
  • 2021 年價格分析
  • 植入式醫療器械製造材料的採用趨勢
  • 波特分析
  • PESTEL 分析

第 4 章競爭格局，2021 年

  • 介紹
  • 競爭儀表板，2021 年
  • 2021 年公司矩陣分析
  • 2021 年公司股票分析

第 5 章植入式醫療器械市場：按產品分類

  • 主要細分趨勢
  • 心血管系統
    • 起搏器
    • 植入式心律轉復除顫器 (ICD)
    • 心臟再同步化治療 (CRT)
    • 支架
    • 心室輔助裝置
    • 植入式心臟監護儀 (ICM)
    • 其他
  • 骨科
    • 關節重建
    • 外傷固定裝置
    • 脊柱裝置
    • 其他
  • 眼科
    • 用於青光眼的人工晶狀體/植入物
    • 其他
  • 整形外科
    • 乳房植入物
    • 髖關節植入物
  • 神經學
    • 深部腦刺激器
    • 其他
  • 牙科
    • 種植牙
    • 牙冠和基台
    • 其他
  • 其他

第 6 章植入式醫療器械市場：按類型

  • 主要細分趨勢
  • 治療
  • 診斷

第 7 章植入式醫療器械市場：按器械性質分類

  • 主要細分趨勢
  • 活躍
  • 靜態/非主動/被動

第 8 章植入式醫療器械市場：按最終用途分類

  • 主要細分趨勢
  • 醫院
  • 多專業中心
  • 門診手術中心
  • 診所
  • 其他

第 9 章植入式醫療器械市場：按地區

  • 主要區域趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 波蘭
    • 奧地利
    • 瑞士
    • 瑞典
    • 丹麥
    • 斯洛伐克
    • 捷克共和國
    • 芬蘭
    • 比荷盧經濟聯盟
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 台灣
    • 印度尼西亞
    • 泰國
    • 越南
    • 柬埔寨
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿聯酋

第十章公司簡介

  • Medtronic Plc
  • Zimmer Biomet
  • AbbVie Inc.（Allergan plc）
  • MicroPort Scientific Corporation
  • Stryker Corporation
  • Smith & Nephew plc
  • Boston Scientific Corporation
  • Abbott Laboratories, Inc
  • Alcon Laboratories
  • Bausch & Lomb
  • Mindray Medical International Limited
  • POLYTECH Health & Aesthetics
  • MED-EL GmbH
  • Demant A/S
  • Advanced Bionics Corporation（Sonova Holdings AG）
  • Cochlear Limited
  • W. L. Gore & Associates, Inc
  • Johnson & Johnson
  • Henry Schein, Inc
  • BIOTRONIK SE & Co. KG
簡介目錄
Product Code: 4483

Global Implantable Medical Devices Market is expected to expand positively through 2032 owing to the surging preference for biomaterials to accomplish better biocompatibility as well as outcomes. Moreover, a slew of technological innovations in implantable medical devices is expected to boost product performance and clinical results.

To illustrate, Coherent Corporation in early 2023, launched a fully automated laser system, AP 530 S, for marking and texturing implantable medical devices. The process is contactless, which eliminates the risk of contamination and ensures improved level of uniformity and quality for medical devices.

Prominent companies are creating high-end implantable technologies as well as data monitoring applications that offer clinical data regarding patient health and device performance. For instance, in March 2022, Johnson & Johnson revealed that its DePuy Synthes division has introduced two cutting-edge knee implants, the ATTUNE Cementless Fixed Bearing Knee as well as the ATTUNE Medial Stabilized Knee System. The novel product launch helped the firm improve its product portfolio and boost its revenue share.

The implantable medical devices market has been divided in terms of product, type, nature of devices, end-use, and region.

Based on product, the plastic surgery segment is slated to grow at more than 10.5% CAGR from 2023 to 2032. Increased awareness of physical attributes as well as the burgeoning preference for a specific beauty standard is expected to drive market expansion.

With respect to end-use, the hospitals segment is anticipated to attain sizable market expansion over the review years fueled by the deployment of cutting-edge implantable devices in hospital settings that deliver improved outcomes. Other factors favorably influencing the expansion of the hospital segment include rising illness screening programs, growing hospitalizations for chronic disorder treatments, such as heart and orthopedic conditions, as well as rising admissions for heart and orthopedic problems.

From the regional perspective, the Latin America implantable medical devices market is speculated to grow at more than 10% CAGR from 2023 to 2032. The regional expansion is expected to be driven by expanding population base throughout the region and an increase in medical tourism. The demand for technologically improved equipment for the treatment of various diseases is also expected to drive market expansion in the LATAM region.

As per reports, Mexico stands as the second most popular destination for medical tourism worldwide, with an influx of 1.4 million to 3 million people to take advantage of inexpensive treatment.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 North America
    • 1.3.2 Europe
    • 1.3.3 Asia Pacific
    • 1.3.4 Latin America
    • 1.3.5 MEA
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 COVID-19 impact analysis at global level
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Implantable medical devices industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Type trends
    • 2.1.4 Nature of device trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Implantable Medical Devices Industry Insights

  • 3.1 Industry landscape, 2018 - 2032
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of chronic diseases across the globe
      • 3.2.1.2 Scarcity of organ donors
      • 3.2.1.3 Technological advancement in developed nations
      • 3.2.1.4 Rising government funding for implantable medical devices in developed countries
      • 3.2.1.5 Increasing focus on development of microelectronics and implantable sensors
      • 3.2.1.6 Growing adoption of biomaterials for better biocompatibility and outcomes
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of devices
      • 3.2.2.2 Stringent regulations for active implantable medical devices
      • 3.2.2.3 Considerable rate of post-procedural complications
      • 3.2.2.4 High number of recalls of implantable medical devices
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By type
    • 3.3.3 By nature of devices
    • 3.3.4 By end-use
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
    • 3.5.3 Asia Pacific
  • 3.6 Reimbursement scenario
  • 3.7 Technology landscape
  • 3.8 Pricing analysis, 2021
  • 3.9 Trend in adoption of materials for manufacture of implantable medical devices
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Competitive dashboard, 2021
  • 4.3 Company matrix analysis, 2021
  • 4.4 Company market share analysis, 2021

Chapter 5 Implantable Medical Devices Market, By Product

  • 5.1 Key segment trends
  • 5.2 Cardiovascular
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.2 Pacemaker
      • 5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.3 Implantable cardiac defibrillators (ICDs)
      • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.4 Cardiac Resynchronization Therapy (CRT)
      • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.5 Stents
      • 5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.6 Ventricular assist devices
      • 5.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.7 Implantable cardiac monitors (ICM)
      • 5.2.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.8 Others
      • 5.2.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Orthopedic
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Joint reconstruction
      • 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.3 Trauma fixation devices
      • 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.4 Spinal devices
      • 5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.5 Others
      • 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.4 Ophthalmology
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.4.2 Intraocular lenses & glaucoma implants
      • 5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.4.3 Others
      • 5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.5 Plastic surgery
    • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.5.2 Breast implants
      • 5.5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.5.3 Gluteal implants
      • 5.5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.6 Neurology
    • 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.6.2 Deep brain stimulators
      • 5.6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.6.3 Others
      • 5.6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.7 Dental
    • 5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.7.2 Dental implants
      • 5.7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.7.3 Dental crowns & abutment
      • 5.7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.7.4 Others
      • 5.7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.8 Others
    • 5.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Implantable Medical Devices Market, By Type

  • 6.1 Key segment trends
  • 6.2 Treatment
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Diagnostic
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Implantable Medical Devices Market, By Nature of Devices

  • 7.1 Key segment trends
  • 7.2 Active
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3 Static/Non-active/Passive
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Implantable Medical Devices Market, By End-use

  • 8.1 Key segment trends
  • 8.2 Hospitals
    • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.3 Multi-specialty centers
    • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.4 Ambulatory surgical centers
    • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.5 Clinics
    • 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.6 Others
    • 8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Implantable Medical Devices Market Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Poland
    • 9.3.7 Austria
    • 9.3.8 Switzerland
    • 9.3.9 Sweden
    • 9.3.10 Denmark
    • 9.3.11 Slovakia
    • 9.3.12 Czech Republic
    • 9.3.13 Finland
    • 9.3.14 Benelux
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Taiwan
    • 9.4.7 Indonesia
    • 9.4.8 Thailand
    • 9.4.9 Vietnam
    • 9.4.10 Cambodia
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Medtronic Plc
  • 10.2 Zimmer Biomet
  • 10.3 AbbVie Inc. (Allergan plc)
  • 10.4 MicroPort Scientific Corporation
  • 10.5 Stryker Corporation
  • 10.6 Smith & Nephew plc
  • 10.7 Boston Scientific Corporation
  • 10.8 Abbott Laboratories, Inc
  • 10.9 Alcon Laboratories
  • 10.10 Bausch & Lomb
  • 10.11 Mindray Medical International Limited
  • 10.12 POLYTECH Health & Aesthetics
  • 10.13 MED-EL GmbH
  • 10.14 Demant A/S
  • 10.15 Advanced Bionics Corporation (Sonova Holdings AG)
  • 10.16 Cochlear Limited
  • 10.17 W. L. Gore & Associates, Inc
  • 10.18 Johnson & Johnson
  • 10.19 Henry Schein, Inc
  • 10.20 BIOTRONIK SE & Co. KG